Wei Chen1, David R Janz2, Ciara M Shaver3, Gordon R Bernard3, Julie A Bastarache3, Lorraine B Ware3. 1. Division of Allergy, Pulmonary, and Critical Care Medicine, Louisiana State University School of Medicine, New Orleans, LA; Vanderbilt University School of Medicine, Nashville, TN; the Division of Pulmonary and Critical Care Medicine, Louisiana State University School of Medicine, New Orleans, LA; Chiayi Christian Hospital, Chiayi, Taiwan; the Department of Life Science, Louisiana State University School of Medicine, New Orleans, LA; National Chung Hsing University, Taichung, Taiwan; the College of Nursing, Louisiana State University School of Medicine, New Orleans, LA. Electronic address: peteralfa2004@yahoo.com.tw. 2. Da-Yeh University, Taichung, Taiwan; and the Section of Pulmonary and Critical Care Medicine, Louisiana State University School of Medicine, New Orleans, LA. 3. Division of Allergy, Pulmonary, and Critical Care Medicine, Louisiana State University School of Medicine, New Orleans, LA.
Abstract
BACKGROUND: Oxygen saturation as measured by pulse oximetry/Fio2 (SF) ratio is highly correlated with the Pao2/Fio2 (PF) ratio in patients with ARDS. However, it remains uncertain whether SF ratio can be substituted for PF ratio for diagnosis of ARDS and whether SF ratio might identify patients who are systemically different from patients diagnosed by PF ratio. METHODS: We conducted a secondary analysis of a large observational prospective cohort study. Patients were eligible if they were admitted to the medical ICU and fulfilled the Berlin definition of ARDS with hypoxemia criteria using either the standard PF threshold (PF ratio ≤ 300) or a previously published SF threshold (SF ratio ≤ 315). RESULTS: Of 362 patients with ARDS, 238 (66%) received a diagnosis by PF ratio and 124 (34%) by SF ratio. In a small group of patients who received diagnoses of ARDS by SF ratio who had arterial blood gas measurements on the same day (n = 10), the PF ratio did not meet ARDS criteria. There were no major differences in clinical characteristics or comorbidities between groups with the exception of APACHE (Acute Physiology and Chronic Health Evaluation) II scores, which were higher in the group diagnosed by PF ratio. However, this difference was no longer apparent when arterial blood gas-dependent variables (pH, Pao2) were removed from the APACHE II score. There were also no differences in clinical outcomes including duration of mechanical ventilation (mean, 7 days in both groups; P = .25), duration of ICU stay (mean, 10 days vs 9 days in PF ratio vs SF ratio; P = .26), or hospital mortality (36% in both groups, P = .9). CONCLUSIONS: Patients with ARDS diagnosed by SF ratio have very similar clinical characteristics and outcomes compared with patients diagnosed by PF ratio. These findings suggest that SF ratio could be considered as a diagnostic tool for early enrollment into clinical trials.
BACKGROUND:Oxygen saturation as measured by pulse oximetry/Fio2 (SF) ratio is highly correlated with the Pao2/Fio2 (PF) ratio in patients with ARDS. However, it remains uncertain whether SF ratio can be substituted for PF ratio for diagnosis of ARDS and whether SF ratio might identify patients who are systemically different from patients diagnosed by PF ratio. METHODS: We conducted a secondary analysis of a large observational prospective cohort study. Patients were eligible if they were admitted to the medical ICU and fulfilled the Berlin definition of ARDS with hypoxemia criteria using either the standard PF threshold (PF ratio ≤ 300) or a previously published SF threshold (SF ratio ≤ 315). RESULTS: Of 362 patients with ARDS, 238 (66%) received a diagnosis by PF ratio and 124 (34%) by SF ratio. In a small group of patients who received diagnoses of ARDS by SF ratio who had arterial blood gas measurements on the same day (n = 10), the PF ratio did not meet ARDS criteria. There were no major differences in clinical characteristics or comorbidities between groups with the exception of APACHE (Acute Physiology and Chronic Health Evaluation) II scores, which were higher in the group diagnosed by PF ratio. However, this difference was no longer apparent when arterial blood gas-dependent variables (pH, Pao2) were removed from the APACHE II score. There were also no differences in clinical outcomes including duration of mechanical ventilation (mean, 7 days in both groups; P = .25), duration of ICU stay (mean, 10 days vs 9 days in PF ratio vs SF ratio; P = .26), or hospital mortality (36% in both groups, P = .9). CONCLUSIONS:Patients with ARDS diagnosed by SF ratio have very similar clinical characteristics and outcomes compared with patients diagnosed by PF ratio. These findings suggest that SF ratio could be considered as a diagnostic tool for early enrollment into clinical trials.
Authors: Robinder G Khemani; Neal J Thomas; Vani Venkatachalam; Jason P Scimeme; Ty Berutti; James B Schneider; Patrick A Ross; Douglas F Willson; Mark W Hall; Christopher J L Newth Journal: Crit Care Med Date: 2012-04 Impact factor: 7.598
Authors: Hollis R O'Neal; Tatsuki Koyama; Elizabeth A S Koehler; Edward Siew; Blake R Curtis; Richard D Fremont; Addison K May; Gordon R Bernard; Lorraine B Ware Journal: Crit Care Med Date: 2011-06 Impact factor: 7.598
Authors: Gordon D Rubenfeld; Ellen Caldwell; Eve Peabody; Jim Weaver; Diane P Martin; Margaret Neff; Eric J Stern; Leonard D Hudson Journal: N Engl J Med Date: 2005-10-20 Impact factor: 91.245
Authors: Jesús Villar; Lina Pérez-Méndez; Jesús Blanco; José Manuel Añón; Lluís Blanch; Javier Belda; Antonio Santos-Bouza; Rosa Lidia Fernández; Robert M Kacmarek Journal: Intensive Care Med Date: 2013-01-31 Impact factor: 17.440
Authors: Niall D Ferguson; Eddy Fan; Luigi Camporota; Massimo Antonelli; Antonio Anzueto; Richard Beale; Laurent Brochard; Roy Brower; Andrés Esteban; Luciano Gattinoni; Andrew Rhodes; Arthur S Slutsky; Jean-Louis Vincent; Gordon D Rubenfeld; B Taylor Thompson; V Marco Ranieri Journal: Intensive Care Med Date: 2012-08-25 Impact factor: 17.440
Authors: Pratik P Pandharipande; Ayumi K Shintani; Heather E Hagerman; Paul J St Jacques; Todd W Rice; Neal W Sanders; Lorraine B Ware; Gordon R Bernard; E Wesley Ely Journal: Crit Care Med Date: 2009-04 Impact factor: 7.598
Authors: V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky Journal: JAMA Date: 2012-06-20 Impact factor: 56.272
Authors: David E Leaf; Edward D Siew; Michele F Eisenga; Karandeep Singh; Finnian R Mc Causland; Anand Srivastava; T Alp Ikizler; Lorraine B Ware; Adit A Ginde; John A Kellum; Paul M Palevsky; Myles Wolf; Sushrut S Waikar Journal: Clin J Am Soc Nephrol Date: 2018-03-08 Impact factor: 8.237
Authors: Tatiana Baranovich; Jeremy C Jones; Marion Russier; Peter Vogel; Kristy J Szretter; Susan E Sloan; Patrick Seiler; Jose M Trevejo; Richard J Webby; Elena A Govorkova Journal: Antimicrob Agents Chemother Date: 2016-03-25 Impact factor: 5.191
Authors: Samuel M Brown; Colin K Grissom; Marc Moss; Todd W Rice; David Schoenfeld; Peter C Hou; B Taylor Thompson; Roy G Brower Journal: Chest Date: 2016-01-19 Impact factor: 9.410